UY38137A - Una forma de dosificación oral sólida farmacéutica de solifenacina - Google Patents

Una forma de dosificación oral sólida farmacéutica de solifenacina

Info

Publication number
UY38137A
UY38137A UY0001038137A UY38137A UY38137A UY 38137 A UY38137 A UY 38137A UY 0001038137 A UY0001038137 A UY 0001038137A UY 38137 A UY38137 A UY 38137A UY 38137 A UY38137 A UY 38137A
Authority
UY
Uruguay
Prior art keywords
dosage form
solifenacin
oral dosage
solid oral
solid
Prior art date
Application number
UY0001038137A
Other languages
English (en)
Spanish (es)
Inventor
Villarreal Ana Purón
Munárriz Ainara Lecumberri
Original Assignee
Intas Third Party Sales 2005 S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Third Party Sales 2005 S L filed Critical Intas Third Party Sales 2005 S L
Publication of UY38137A publication Critical patent/UY38137A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
UY0001038137A 2018-03-08 2019-03-06 Una forma de dosificación oral sólida farmacéutica de solifenacina UY38137A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382149 2018-03-08
EP18382472 2018-06-26

Publications (1)

Publication Number Publication Date
UY38137A true UY38137A (es) 2019-07-31

Family

ID=65598664

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038137A UY38137A (es) 2018-03-08 2019-03-06 Una forma de dosificación oral sólida farmacéutica de solifenacina

Country Status (5)

Country Link
JP (1) JP2021526504A (fr)
MX (1) MX2020009204A (fr)
TW (1) TW201938163A (fr)
UY (1) UY38137A (fr)
WO (1) WO2019170795A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ23090U1 (cs) 2004-03-25 2011-12-19 Astellas Pharma Inc. Kompozice pevného farmaceutického prípravku solifenacinu nebo jeho soli
US9050249B2 (en) 2004-04-30 2015-06-09 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition
EP2146693A2 (fr) * 2007-04-11 2010-01-27 Dr. Reddy's Laboratories Ltd. Compositions à base de solifénacine
LT2572717T (lt) * 2010-05-19 2016-09-26 Astellas Pharma Inc. Farmacinė kompozicija turinti solifenacino

Also Published As

Publication number Publication date
JP2021526504A (ja) 2021-10-07
WO2019170795A1 (fr) 2019-09-12
TW201938163A (zh) 2019-10-01
MX2020009204A (es) 2021-01-15

Similar Documents

Publication Publication Date Title
ECSP17013617A (es) “combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y nsaid”
EA201591751A1 (ru) Трипептидные эпоксикетонные ингибиторы протеазы
CL2019001366A1 (es) Formulaciones tamponadas exendina (9-39).
JP2015517488A5 (fr)
RU2017116740A (ru) Комбинации для лечения рассеянного склероза
SI2889033T1 (en) Treatment of negative symptoms of schizophrenia with (R) -7-chloro-N- (chonylidin-3-yl) benzo (B) thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
MX2021002321A (es) Nuevos metodos.
MX2015009055A (es) Forma de dosificacion oral de liberacion sostenida gastro retentiva de un secuestrante de acido biliar.
PH12019502651A1 (en) Use of vibegron to treat overactive bladder
JP2016512817A5 (fr)
BR112019003136A2 (pt) forma de dosagem multiunitária de composição farmacêutica, forma de dosagem unitária de composição farmacêutica, forma de dosagem multiunitária / unitária, kit e método de tratamento de uma condição tratável por administração oral de um agente terapeuticamente ativo
IL292655A (en) Combined therapy of c-c cytokine receptor type 9 (ccr9) inhibitors and integrin-blocking anti-alha4beta7 antibodies
MX2020007971A (es) Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar.
AR099299A1 (es) Inhibidor de la proteína de transferencia de éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden dicho inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares
TR201819662T4 (tr) Çocukluk çağı hipertansiyon tedavisinde kullanılan enalapril içeren ağızda dağılan film bileşimi.
CL2019002808A1 (es) Métodos para prevenir o tratar enfermedades oftálmicas.
UY31826A (es) Compuesto peptídico y su uso
CO7170181A2 (es) Nueva composición de alfentanilo para el tratamiento del dolor agudo
EA202090445A1 (ru) ПРОТИВОГРИБКОВЫЕ СРЕДСТВА С ПОВЫШЕННОЙ АКТИВНОСТЬЮ ПРИ КИСЛОМ pH
UY38137A (es) Una forma de dosificación oral sólida farmacéutica de solifenacina
UA115250C2 (uk) Фармацевтичні комбінації
AR114378A1 (es) Una forma de dosificación oral sólida farmacéutica de solifenacina
MX2013001279A (es) Composicion farmaceutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral.
RU2015122833A (ru) Способ лечения хронического эндометрита
AR068608A1 (es) Neramexano para el tratamiento de nistagmo